FDA Orders Cancer Warning For TNF Blockers
The U.S. Food and Drug Administration has announced that it will require a class of drugs known as tumor necrosis factor alpha blockers to include a stronger warning highlighting the possibility...To view the full article, register now.
Already a subscriber? Click here to view full article